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Abstract
Background: Dementia is often not formally diagnosed in primary care. To what extent this is due to family
physicians’ (FPs) watchful waiting, reluctance to diagnose or to their unawareness of the presence of cognitive
impairment is unclear. The objective of this study was to assess FPs’ awareness of cognitive impairment by
comparing their evaluation of the absence or presence of cognitive impairment in older patients without an
established diagnosis of dementia, with a reference test of cognitive functioning. In addition, we assessed which
patient characteristics were associated with con- and discordance between FPs’ evaluation of cognition and results
of the reference test.
Methods: The design was a nested diagnostic study. FPs (n = 29) of 15 primary care practices classified the
cognitive status of all their patients ≥ 65 years of age (n = 7865) into four categories, based on recollection and
medical records. All patients categorized as ‘possible cognitive impairment or dementia’ and a sample of patients
categorized as ‘no signs of cognitive impairment’ randomly selected to match age and gender were offered to
receive a reference test of cognitive function (the CAMCOG) to verify the FPs’ label. This reference test could yield
three outcomes: no cognitive impairment, amnestic mild cognitive impairment (aMCI) or dementia. Reference test
results were weighted back to the original samples to provide estimates for the correct categorization of elderly as
‘possible cognitive impairment or dementia’ (positive predictive value [PPV]) and ‘no signs of cognitive impairment’
(negative predictive value [NPV]). Cognitive functioning was not assessed for patients evaluated by FPs as ‘probable
dementia’ and ‘unknown or no recent contact’. Characteristics associated with the con- or discordance of the FPs’
classification and the reference test were assessed using logistic regression.
Results: Complete reference test results were obtained from 318 elderly. FPs labeled 8.3 % of elderly ‘possible
cognitive impairment or dementia’. The PPV of this label for a CAMCOG score suggestive of dementia or aMCI was
47.1 % (95 %-confidence interval: 43.5 – 62.4 %). FPs labeled 83.7 % ‘no signs of cognitive impairment’. The 1-NPV
of this label for a CAMCOG score suggestive of dementia or aMCI was 12.5 % (95 %-CI 8.2 – 16.8 %). FPs labeled
3.6 % as ‘probable dementia’ and 4.5 % as ‘unknown or no recent contact’. The odds that FPs’ suspicion of
cognitive impairment were confirmed by the CAMCOG were higher if persons were ADL dependent (OR 2.24
[95 %-CI 1.16 – 4.35]). The odds of FPs being unaware of the presence of cognitive impairment were higher in the
older elderly (OR 1.15 [95 %-CI 1.09 – 1.23] per year).
Conclusion: Evaluation of FPs’ classification of the global cognitive function of elderly without a firm diagnosis of
dementia showed both over- and unawareness of the presence of cognitive impairment. FPs were more often
unaware of cognitive impairment in the older elderly.
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Background
Late or missed dementia diagnoses are not uncommon in
the primary care setting. The percentage of all dementia
cases within a practice that are diagnosed ranges from 14
to 33 % for mild, and from 38 to 71 % for moderate to se-
vere dementia [1]. Currently, there is a lot of emphasis on
early diagnosis of dementia, mostly by policy makers, and
FPs are sometimes ‘accused’ of diagnostic reluctance or
said to be in need of more training [2–5]. This plea for
‘more dementia diagnoses’ is countered by people stating
that the diagnosis of dementia is a cumulative process and
that FPs weigh carefully whether and when this high im-
pact diagnosis is opportune in every individual case [3].
What is missing in this discussion about whether or not
FPs should proceed more rigorously, is information about
how often FPs are at all aware of cognitive impairment
[6, 7]. Another thing missing is information about the pre-
dictive value of such awareness for the actual presence or
absence of cognitive impairment. Earlier studies on FPs’
diagnostic accuracy provide only limited information since
their outcomes (e.g. sensitivity) always concerned already
diagnosed patients, whereas diagnostic gain can only be
achieved in individuals without an established diagnosis of
dementia [1]. Possible outcomes of diagnostic evaluation of
cognition by FPs comprise dementia, mild cognitive impair-
ment, cognitive functioning normal for age or other causes
for memory impairment such as affective disorders [8].
The aim of the current study was to estimate FPs’ aware-
ness of the presence or absence of cognitive impairment
and dementia among older persons without an established
diagnosis of dementia by comparing their evaluation of the
cognitive function of their older patients with a reference
test. In addition, we assessed which patient characteristics
were associated with con- and discordance between FPs’
evaluation of cognition and reference test results.
Methods
Design
We used a prospective nested design to study the diagnos-
tic accuracy of FPs’ classification of the cognitive status of
the older persons in their practices. Biesheuvel et al. de-
scribed this design in detail [9, 10].
This study was a sub-study within a cluster RCT [11].
Cognitive classification by FPs
At baseline the FPs of the 15 Primary Care Practices (PCPs)
were provided with a list of all their patients aged 65 and
above and asked to classify them in one of the following
four categories:
 ‘no signs of cognitive impairment’ (negative index
test)
 ‘possible cognitive impairment or dementia’ (positive
index test)
 ‘probable dementia’
 ‘unknown or no recent contact’
FPs categorized based on their recollection. They were
allowed to check their electronic medical records (EMR) if
they wanted, but not to perform additional cognitive tests.
There was no feedback to patients about the categorization.
The index test
Since we were particularly interested in FPs’ awareness of
cognitive impairment in cases where the diagnosis was
not yet evident, we aimed to validate the label ‘possible
cognitive impairment or dementia’ (positive index test).
To explore unawareness, we validated the label ‘no signs
of cognitive impairment’ (negative index test). Since previ-
ous literature demonstrated a high validity of the label
‘probable dementia’ by FPs, we assumed this would also
apply to this classification by the FPs who participated in
this study and chose not to validate this label [1].
Determinants of cognitive classification by the FPs
A post hoc analysis was performed to assess whether the
following patient characteristics were associated with being
classified as ‘possible cognitive impairment or dementia’ or
‘no signs of cognitive impairment’: mental health status and
quality of life (MH5, EQ-5D, QoL-AD), number of comor-
bidities, the presence of chronic diseases, the presence of
psychiatric disorders, whether living alone or together and
level of ADL and instrumental-ADL dependency (Katz).
The reference standard
We needed a reference test that differentiated between nor-
mal cognition for age and cognitive impairment, including
aMCI and dementia. We chose the Cambridge Cognitive
Examination (CAMCOG) as a reference standard as it
meets this criterion and has good reliability and psychomet-
ric properties [12, 13]. The sensitivity and specificity of this
instrument for dementia as assessed by clinically trained
experts using the DSM IV criteria are 93 and 87 %, respect-
ively; and for amnestic MCI (aMCI) 78 and 74 %, respect-
ively [12–15]. The CAMCOG was administered by trained
interviewers blinded to the FPs’ classification (n = 5), and
scored according to the CAMCOG scoring guideline. We
used established age and education specific cut-offs for
optimal test accuracy. The cut-off for dementia for indi-
viduals younger than 75 years of age with low education
is < 83; with moderate or high education < 84; for individ-
uals of 75 years of age or older with low education < 65;
with moderate or high education < 78 [14, 16]. The cut-off
for aMCI for individuals with low education is < 26; with
moderate or high education < 28 [12]. As the formal diag-
nosis of dementia requires the presence of functional
impairment in addition to cognitive impairment, we also
used Lawton and Brody’s scale on instrumental activities
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of daily living (iADL) to estimate the presence of dementia
[17]. Finally, we used the delirium observation scale to
rule out delirium [18].
Participant recruitment, sampling strategy and data
collection
All 647 patients labeled ‘possible cognitive impairment or
dementia’ (positive index test) were invited for study par-
ticipation. From the group labeled ‘no signs of cognitive
impairment’ (negative index test) (n = 6582), a random, age
and gender matched sample of 442 patients was invited to
participate. Patients were included between October 2011
and May 2012. Due to a delay in the assessment of our
study protocol by the medical ethics committee, the mean
time between index and reference test was 8.9 months (SD
4.6 months).
Outcomes
The accuracy of FPs awareness of cognitive impairment
was expressed as PPV and NPV. Since we were interested
in cases where FPs were unaware of it, while cognitive
impairment was present, we decided to present the 1-NPV
instead of the NPV in the results section. The primary
comparison was the FPs’ label versus the reference cat-
egory ‘dementia or aMCI’. The secondary comparison was
the the FPs’ label versus the reference category ‘dementia’
alone.
Determinants of agreement between the cognitive
classification by FPs and the reference test
We also assessed whether the following patient characteris-
tics were associated with con- and discordance between
FPs’ evaluation of cognition and results of the reference
test: gender, age, contact frequency, time registered with FP,
living alone or not and level of ADL- and instrumental-
ADL dependency.
Non-response analysis
To assess whether selective non-response occurred, a
non-response analysis was performed in a sample of 210
individuals in four Primary Care Practices (PCPs) providing
sufficient numbers of both respondents and non-respondents
to allow statistical comparison. These PCPs were se-
lected to reflect both ends of the classification spectrum
(positive index test rates ranging from 6.0 to 11.6 %).
To test our hypothesis that there may be more individ-
uals with cognitive impairment among non-respondents,
anonymous data on non-respondents were gathered. The
results of all cognitive tests performed by medical staff as
part of standard care were used. To allow comparison, FPs
participating in the non-response analysis agreed to use the
CAMCOG instead of the MMSE to test the cognitive sta-
tus among non-respondents, during the time of the non-
response analysis. FPs or their staff obtained informed
consent to use the anonymous results of the single cogni-
tive tests for study purposes.
Statistical analysis
Logistic regression was used to assess which patient char-
acteristics other than age and the CAMCOG score were
associated with FPs’ judgment on the presence or absence
of cognitive impairment. We adjusted for age and for the
raw CAMCOG score.
The PPV and 1-NPV were defined as the proportion of
patients with FPs’ label ‘possible cognitive impairment or
dementia’ that were cognitively impaired according to the
reference test and the proportion of patients with FPs’ label
‘no signs of cognitive impairment’ that were not cognitively
impaired according to the reference test, respectively [14].
As the sample selected to receive the reference test from
the latter group was matched to the group labeled ‘possible
cognitive impairment or dementia’ on age and gender, we
used sampling weights to estimate the NPV. Sampling
weights were taken as the inverse of the proportion of
patients within the stratum for which reference test results
were obtained. The same strategy was used to correct for
non-response in the group labeled as ‘possible cognitive
impairment or dementia’. Stata 12 was used to obtain confi-
dence intervals for the weighed diagnostic accuracy mea-
sures. Although clustering effects on the FP level were
assumed likely, confidence intervals presented were not
corrected for clustering due to the small cluster size and
binary nature of the outcome.
Logistic regression was used to assess which patient
characteristics were associated with con- and discordance
between FPs’ evaluation of cognition and results of the
reference test.
To explore potential selection bias, we compared age,
gender and cogntive status between respondents and non-
respondents in four primary care practices using chi-
square and t-tests. The odds ratio of dementia or aMCI
according to the CAMCOG in respondents versus non-
respondents was calculated.
To assess whether the time that elapsed between index
and reference had any substantial effect on our outcomes,
we used follow-up data from the RCT of which this study
was part and compared the number of dementia and
aMCI cases based on the CAMCOG scores at baseline
(this study) and 1-year follow-up (the RCT). In addition,
we calculated the OR of a concordant versus a discordant
cognitive classification as a function of the time between
index and reference test. SPSS Statistics® 20 and Stata® 12
were used for the analysis.
Ethics committee approval
Ethical approval for the study was obtained from the med-
ical ethics committee of the VU University Medical Center
Amsterdam, The Netherlands (reference number 2010/
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297). The study protocol is in accordance with the princi-
ples of the current version of the declaration of Helsinki.
Written informed consent was obtained from all study
participants.
The STARD criteria for the reporting of studies of diag-
nostic accuracy were used to write this paper [19].
Results
Cognitive classification by FPs
Of all 7.865 elderly in the practices, 83.7 % (n = 6582)
were labelled ‘no signs of cognitive impairment’ (nega-
tive index test) by FPs; 8.2 % (n = 647) were labeled
‘possible cognitive impairment or dementia’ (positive
index test), 3.6 % (n = 284) ‘probable dementia’ and
4.5 % (n = 352) ‘unknown or no recent contact’.
Cognitive classification at practice level
There was substantial variation between practices in the
distribution of index test outcomes. FPs classified between
32.3 and 94.7 % of older persons as ‘no signs of cognitive
impairment’ and between 2.0 and 21.1 % as ‘possible cog-
nitive impairment or dementia’. However, two younger
recently settled FPs appeared outliers with much higher
rates of the label ‘unaware or no recent contact’ than other
FPs and also relatively high rates of ‘possible cognitive
impairment or dementia’. Without these two, the lowest
percentage labeled ‘no signs of cognitive impairment’ was
77.1 % and the highest percentage ‘possible cognitive
impairment or dementia’ was 14.0 %. Classifications per
practice are shown in Additional file 1: Appendix 1, with
PCP 12 and 16 being the outliers.
Family Physician and Primary Care Practice characteristics
Half of the participating FPs (n = 29) was female, the
mean age of FPs was 49.5 (SD 8.9) years old and they
had 16.5 (SD 9.3) years of experience. The average prac-
tice counted 3001 (SD 724) patients of whom 16.6 %
(SD 6.3 %) were 65 years or older. For comparison, of all
Dutch FPs (n = 8902) 41 % is female, their mean age is
48.4 (SD 9.0) years and they have 15.1 (SD 10.0) years of
experience. The average practice (more than one FP)
population size in the Netherlands is 4204 patients with
15.9 % of them aged 65 years or older [20].
Determinants of cognitive classification by the FPs
As expected, the mean age of individuals with the label
‘possible cognitive impairment or dementia’ (n = 6582;
mean age 80 (SD 7.3)) was higher than that of individuals
with ‘no signs of cognitive impairment’ (n = 647; mean age
73.7 (SD 6.5), p < 0.001). The percentage of females was
58.0 and 54.7 %, respectively (p = 0.11). Patients with more
comorbidities (OR 7.46, 95 %-CI 4.00 – 14.08) and a higher
level of iADL dependency (OR 1.61 95 %-CI 1.03 – 1.31)
had a higher chance of having the label ‘possible cognitive
impairment or dementia’ instead of ‘no signs of cognitive
impairment’, irrespective of their age and CAMCOG score.
Response rate
A complete reference standard was obtained from 142
(22 %) of all patients labeled ‘possible cognitive impairment
or dementia’ and from 176 (40 %) of randomly sampled age
and gender matched patients with ‘no signs of cognitive
impairment’. Figure 1 provides a flow chart of the inclusion
process.
Prior chance of cognitive impairment in all participating
elderly
The prior chance of a CAMCOG score below the age and
education specific cut-off for dementia and/or a memory
section score below the cut-off for aMCI in older persons
with a positive and negative index test together was
15.6 %. The prior chance of a CAMCOG score suggestive
of dementia was 11.9 %. The prior chance of a CAMCOG
score below the cut-off and iADL dependency was 7.6 %.
PPV of FPs’ label ‘possible cognitive impairment or
dementia’ and NPV of FPs’ label ‘no signs of cognitive
impairment’
The weighted PPV of the FP label ‘possible cognitive im-
pairment or dementia’ for a CAMCOG score below the
age and education specific cut-offs for dementia or aMCI
was 47.1 % (95 %-confidence interval: 43.5 – 62.4 %). The
1-NPV of the FP label ‘no signs of cognitive impairment’
for a CAMCOG score suggestive of dementia and aMCI
was 12.5 % (95 %-CI 8.2 – 16.8 %). Table 1 provides an
overview of the results. FPs’ classification is also compared
to the reference category ‘dementia’ alone and presented
separately for men and women.
PPV and NPV without outliers
When the two FP outliers were excluded, the PPV of the
label ‘possible cognitive impairment or dementia’ for a
CAMCOG score suggestive of dementia or aMCI became
51.9 % (95 %-CI: 41.9 – 61.8 %). The 1-NPV of the label ‘no
signs of cognitive impairment’ for a CAMCOG score
suggestive of dementia and aMCI became 11.8 % (95 %-CI:
7.4 – 16.3 %).
Determinants of agreement between the cognitive
classification by FPs and the reference test
We explored whether gender, age, contact frequency,
time registered with FP, living alone or together with
others and level of (instrumental) ADL dependency
predicted concordance or discordance between FPs’
classification of the cognitive status and classification
based on the CAMCOG results.
The chance of discordance between FPs’ label ‘no signs
of cognitive impairment’ and the CAMCOG classification
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increased with age; the OR of a discordant versus a con-
cordant classification was 1.15 (95 %-CI 1.09 – 1.23) per
year older.
The chance of concordance between FPs’ label ‘possible
cognitive impairment or dementia’ was higher if persons
were more dependent of others in their ADL and
instrumental-ADL (i-ADL); the OR of concordant versus
a discordant classification was 2.24 (95 %-CI 1.16 – 4.35)
for persons who were versus persons who were not
ADL dependent and 1.69 (95 %-CI 1.26 – 2.27) for
persons who were versus were not i-ADL dependent.
None of the other characteristics was significantly asso-
ciated with con- or discordance of the classification.
Exploration of selective non-response
Respondents were younger and more often male than
non-respondents, both in the group where FPs suspected
cognitive impairment and in the group where they had
not noticed signs of it. The mean ages of respondents
and non-respondents with suspected cognitive impairment
Fig. 1 Flow chart of the inclusion process
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were 78.1 and 80.7 years, respectively (p < 0.01). The mean
ages of respondents and non-respondents in whom FPs
had not noticed signs of cognitive impairment were 78.6
and 80.2 years, respectively (p = 0.02). The proportions of
females among respondents and non-respondents with sus-
pected cognitive impairment were 42.1 and 63.1 %, respect-
ively (p < 0.01) and among individuals with no signs of
cognitive impairment 53.0 and 63.2 %, respectively (p =
0.03).
In the four PCPs included in the non-response analysis,
there were 53 (25 %) respondents and 157 (75 %) non-
respondents. We compared the rate of CAMCOG scores
below the cut-off for dementia between respondents and
non-respondents. A complete CAMCOG was obtained
from 52 respondents (98 %) and 46 non-respondents
(29 %). The age and gender corrected OR was 0.97 (95 %-
CI 0.51 – 1.87) for a CAMCOG suggestive of dementia in
respondents compared to non-respondents.
Exploration of the effect of time between index and
reference test
The odds of a concordant versus a discordant classification
were similar among individuals with a short and a longer
time between index and reference test (OR 1.05 per month,
95 %-CI 0.96 – 1.13). The development of the CAMCOG
outcome of 105 individuals from whom a CAMCOG was
obtained at baseline and at 1 year follow-up (data from the
RCT of which this study was part) is provided in Additional
file 2: Appendix 2. Although there were quite some shifts
from normal ageing to aMCI or dementia and vice versa
at the individual level, the total number of respondents
with aMCI or dementia was comparable at baseline and
1-year follow-up. The McNemar test, applied to compare
the percentage with ‘aMCI or dementia’ at baseline and 1-
year follow-up (p = 1.00) and the percentage with ‘demen-
tia’ at baseline and 1-year follow-up (p = 0.82) showed
non-significant differences.
Discussion
Summary of main findings
FPs labeled 3.6 % of older persons with ‘probable dementia’,
8.2 % with ‘possible cognitive impairment or dementia’,
83.7 % ‘no signs of cognitive impairment’. They could not
label the remaining 4.5 % of elderly. Persons labelled ‘pos-
sible cognitive impairment or dementia’ had more comor-
bidities and were more often iADL dependent than persons
labelled ‘no signs of cognitive impairment’, irrespective of
their age and CAMCOG score.
The CAMCOG did not confirm the presence of ei-
ther dementia or aMCI in half of the persons in whom
FPs considered cognitive impairment possibly present.
The CAMCOG indicated some form of cognitive im-
pairment in 12.5 % and suggested dementia in 10 % of
persons in whom FPs were not aware of any such
signs.
If we translate these figures to the average practice in
this study with 3000 patients of whom 16.6 % (n = 498)
are above the age of 65, FPs would suspect cognitive im-
pairment in 41 persons. The CAMCOG would confirm
this suspicion in 19, and would not confirm it in 22 per-
sons. FPs would be unaware of cognitive impairment in
52 persons in which the CAMCOG would suggest such
impairment.
There was substantial variation in the percentage of
persons per cognitive category between FPs. Since the
numbers were too small to provide estimates on PPV
and NPV at practice level, it was not possible to deter-
mine the impact of case-mix differences on PPV and
NPV variation between FPs. FPs who provided care for
their population for less than three years could not
classify the cognitive status of 35 to 40 % of their older
patients.
Awareness of cognitive impairment was associated
with ADL- and with iADL dependency; unawareness of
cognitive impairment was associated with higher age.
Table 1 Overview of correspondence of FP classification with the reference standard
PPV PPV women PPV men NPV NPV women NPV men
CAMCOG suggests: % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Dementia or aMCI 47.1 (43.5 – 62.4) 55.8 (43.0 – 68.5) 35.3 (24.2 – 46.5) 87.5 (83.2 – 91.8) 87.8 (82.6 – 93.1) 87.1 (79.9 – 94.4)
Dementia 34.0 (24.8 – 43.2) 38.1 (27.5 – 48.9) 28.5 (17.9 – 39.0) 90.4 (86.5 – 94.3) 92.1 (87.9 – 96.2) 88.2 (81.1 – 95.4)
Dementia & iADLda 25.6 (14.8 – 36.5) 32.5 (22.1 – 32.9) 16.9 (7.3 – 26.4) 93.8 (91.2 – 96.4) 93.0 (89.3 – 96.7) 94.8 (91.5 – 98.0)
Without outliersb
Dementia or aMCI 51.9 (41.9 – 61.8) 60.7 (45.7 – 75.7) 40.3 (27.6 – 53.0) 88.2 (83.7 – 92.6) 87.5 (81.3 – 93.6) 89.0 (82.5 – 95.5)
Dementia 37.3 (28.4 – 46.2) 41.2 (28.4 – 54.1) 32.2 (19.9 – 44.4) 91.6 (88.0 – 95.3) 92.9 (88.7 – 97.2) 90.1 (83.7 – 96.4)
Dementia & iADLda 26.5 (15.3 – 37.7) 31.8 (20.6 – 43.4) 19.8 (8.4 – 30.7) 94.4 (91.9 – 96.9) 94.2 (90.8 – 97.6) 94.6 (91.2 – 98.0)
a Dependency on at least one instrumentalADL item of the Lawton and Brody scale [17]
b Analysis without the cognitive classification of two FPs who were unaware of the cognitive status in a relatively high proportion of elderly (PCP 12 and 16 in
the appendix)
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Strengths and limitations
By using a nested design we guaranteed an accurate repre-
sentation of the source population in our sample and facili-
tated correction for age and sex [9, 10]. Furthermore, the
method used appears to be appropriate to estimate FPs’ ac-
tual awareness or unawareness of dementia and aMCI, since
not having to discuss their suspicion with the patient or
document it in the medical records likely reduced barriers
to identifying someone as possibly cognitively impaired.
A limitation of this study is the low response rate. We
found that respondents were younger and more often male
than non-respondents, although we could not demonstrate
selective non-response related to cognitive status. Never-
theless, since age is strongly associated with cognitive
impairment, correction for age may have reduced such bias
if present. Previous research demonstrated a lower response
rate among individuals with more cognitive impairment
[21]. If present, such a selection would result in underesti-
mation of the PPV but also of the 1-NPV.
Another potential limitation was the time, on average
almost nine months that elapsed between the index and
reference test. Nevertheless, this delay did not seem to
have impact on the estimate of the FPs’ accuracy in our
longitudinal exploration.
The cognitive classification by the FPs had no absolute
demarcation between categories and thus leaves room
for different interpretations. This may have occurred if
FPs doubted between ‘possible’ and ‘probable’ dementia.
We cannot rule out that there were some false positives
among elderly labeled with ‘probable dementia’.
The CAMCOG was validated in a population-based, pur-
posive sample of older people with a relative overrepresen-
tation of high age and cognitive impairment based on
MMSE scores [22]. As a result, the positive predictive value
of the CAMCOG for dementia was likely lower in our
study population. Results from another population based
study support the hypothesis that the CAMCOG may over-
estimate the prevalence of dementia [23, 24]. Since we used
the CAMCOG as a reference standard, the potential effect
on our results would be some underestimation of the PPV
of FPs’ cognitive labels but an overestimation of the NPV of
their labels. In addition, since the CAMCOG was only vali-
dated to measure amnestic MCI and not non-amnestic
MCI, our results include only the amnestic MCI group.
Further, we found substantial shifts in cognitive
classification based on the CAMCOG between baseline
and 1-year follow-up. This may have several causes: it may
be a result of test-retest characteristics of the CAMCOG,
the drop in the cut-off scores at the age of 75 (which caused
a category shift in three respondents), the included popu-
lation with predominantly earlier stages of cognitive im-
pairment, and also treatment of specific conditions (e.g.
heart failure) which may improve cognitive functioning in
between tests may also explain improved CAMCOG
scores [22, 23]. However, since the total rate of CAMCOG
scores suggestive of dementia and MCI remained stable
we presume that these shifts had no substantial effects on
our findings.
One should take into account the impact of the preva-
lence of a condition on the PPV and NPV. If, for example,
the prevalence is very high, the PPV will become higher.
Thus, our findings are prevalence specific and their external
validity is limited to populations with a similar prevalence
of cognitive impairment.
As we focused on persons without a firm diagnosis of
dementia and did not verify patients labeled with ‘probable
dementia’, we could not compute classical diagnostic ac-
curacy measures (e.g. sensitivity and specificity), limiting
the comparability of our results [1, 6].
Comparison with existing literature
A new finding is that the likelihood of missing cognitive
impairment was higher in older elderly. Particularly at earl-
ier stages, FPs may incorrectly attribute signs of cognitive
decline (e.g. dependency, forgetfulness) to normal ageing.
Conversely, FPs may be preoccupied with the multiple
chronic conditions of their older patient, and perhaps over-
look diffuse cognitive impairments if present. Further, we
confirmed the previously described association between
awareness confirmed by a reference test and higher ADL
dependency, showing that also at earlier stages, dependency
is an important clue to cognitive impairment [25].
In contrast to previous findings, living alone was not sig-
nificantly associated with unawareness of present cognitive
impairment in our study [26]. This may reflect that relatives
usually wait to ‘help’ FPs become aware until cognitive
impairment reaches a more advanced stage. Neither did we
find the association between detection and contact fre-
quency that was demonstrated previously [7]. The milder
cognitive impairment and thus more subtle symptoms and
possibly less variation in contact frequency of the studied
group might explain this.
Interpretation
We chose the combined reference test outcome ‘dementia
or aMCI’ for the primary comparison with the index test
because the identification of dementia starts with the recog-
nition of cognitive decline. However, the clinically most
relevant reference test for any index test would - completely
accurately -indicate those patients who would benefit
from treatment of the target condition. In the case of
dementia this is not straightforward. There is no cura-
tive treatment and pharmacological treatment has only
temporary and small effects on cognition and some-
times ADL (and not on other outcomes, like global
impression) and is often accompanied by side-effects if
tolerated at all [27, 28]. Still, there are reasons to estab-
lish this diagnosis: most people would like to know
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about it, support can be offered and care arranged, the
diagnosis may influence medical decisions (e.g. the use of
medication adherence aids) and it may affect the extent to
which patients can be engaged in such decisions [29–32].
To interpret the different reference test outcomes and to
link these outcomes to clinical actions, we would suggest
that further diagnostic evaluation should be considered in
all persons with a CAMCOG score below the cut-off for
dementia, even more so when this is accompanied by
iADL dependency. When the CAMCOG score suggests
only aMCI, the benefit of further diagnostic evaluation is,
due to its variable course, not straightforward in the
primary care setting [33]. Still, there are indications that
persons with MCI are more vulnerable and FPs may con-
sider a more pro-active approach towards these patients
necessary [34–37].
That a substantial proportion of persons in whom FPs’
suspected cognitive impairment scored well on the CAM-
COG suggests that FPs find it hard to distinguish between
earlier stages of cognitive impairment and normal ageing.
This finding contributes to our understanding of un-
established dementia diagnoses in primary care. Unsure-
ness about whether cognitive deficits are at all present
may increase the barrier to raising the issue during regular
consultations with the patient or family. In contrast,
although a decreased level of functioning helps FPs to
become aware of cognitive impairments, the presence of
such functional decline may also be erroneously inter-
preted as a sign of cognitive deterioration.
That a substantial proportion of persons in whom FPs’
had not noticed signs of cognitive impairment had a
CAMCOG score suggestive of aMCI or dementia suggests
that complete unawareness of cognitive impairment is a
major explanatory factor for missed diagnoses of dementia
in primary care. However, this should be seen in context:
awareness is not only a result of how capable FPs are of
recognizing cognitive impairment, but also of whether or
not patients and their relatives bring it to bear (e.g. con-
sultation frequency, discussing versus masking memory
impairment) and of how the healthcare system is orga-
nized (e.g. time available per patient contact).
Still, FPs’ awareness of cognitive impairment is likely
influenced by their own knowledge about symptoms and
signs of dementia and by their attitude regarding the
value of such awareness. This attitude shows quite some
variation: some FPs value establishment of a diagnosis as
a very important part of their function towards the pa-
tient and family, whereas others feel that provision of
good care does not require a diagnosis, or that a diagno-
sis may even be harmful to the patient [25, 38–40].
Implications for practice and future research
A vast body of evidence shows that, although patients’
receptiveness to discuss this topic will vary, the large
majority will appreciate an open attitude to disclose suspi-
cions of dementia [26]. Relatives, although not unequivo-
cally in favour of disclosure towards the patient, do usually
value clarity about the presence of dementia as well [41].
This suggests that FPs may be less hesitant to discuss sus-
pected cognitive impairment.
At present, most guidelines on the diagnosis and man-
agement of dementia do not provide guidance for practi-
tioners on how to diagnose, inform about and manage
cognitive problems other than dementia, like MCI [42, 43].
We assume that if such guidance would be available, this
would decrease barriers for FPs to discuss suspicions of
cognitive impairment.
Like with other missed diagnoses, not considering the
diagnosis at all may be an important cause of FPs’ limited
awareness of cognitive impairment. In this respect, it
would be interesting to explore how FPs awareness would
develop if they would be primed to the possibility of cog-
nitive impairment, for example by performing the classifi-
cation procedure every year. As a results FPs may also
become more alert to other signs of dementia like mis-
takes with repeat medication, gait disturbances, weight
loss or apathy [44–46].
Awareness may also be improved by measures not
directly involving the FP. Other PCP co-workers may
be stimulated to communicate about signs of cognitive
impairment. Public campaigns aimed to reduce fear
and stigma and to inform about available services may
help patients or their relatives seek professional help
sooner [47–49].
Conclusion
Evaluation of FPs’ classification of the global cognitive func-
tion of elderly without a firm diagnosis of dementia showed
both over- and unawareness of the presence of cognitive
impairment. FPs were more often unaware of cognitive
impairment in the oldest old. In contrast, a higher level of
dependency helped them to recognize it. Our findings
suggest that unawareness of cognitive impairment may be
the main cause of un-established dementia diagnoses in pri-
mary care.
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